BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31545689)

  • 1. Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
    Fangusaro J; Wu S; MacDonald S; Murphy E; Shaw D; Bartels U; Khatua S; Souweidane M; Lu HM; Morris D; Panigrahy A; Onar-Thomas A; Fouladi M; Gajjar A; Dhall G
    J Clin Oncol; 2019 Dec; 37(34):3283-3290. PubMed ID: 31545689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors.
    Murphy ES; Dhall G; Fangusaro J; Bartels U; Fouladi M; Shaw D; Khatua S; Hughes CW; Panigraphy A; Ioakeim-Ioannidou M; Souweidane M; Morris D; Gajjar A; Wu S; Onar-Thomas A; Haas-Kogan DA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2022 May; 113(1):143-151. PubMed ID: 34990779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
    Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
    J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
    Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
    Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group.
    Kretschmar C; Kleinberg L; Greenberg M; Burger P; Holmes E; Wharam M
    Pediatr Blood Cancer; 2007 Mar; 48(3):285-91. PubMed ID: 16598761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
    Goldman S; Bouffet E; Fisher PG; Allen JC; Robertson PL; Chuba PJ; Donahue B; Kretschmar CS; Zhou T; Buxton AB; Pollack IF
    J Clin Oncol; 2015 Aug; 33(22):2464-71. PubMed ID: 26101244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study.
    Robertson PL; Jakacki R; Hukin J; Siffert J; Allen JC
    J Neurooncol; 2014 May; 118(1):93-100. PubMed ID: 24700239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
    Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
    Baek HJ; Park HJ; Sung KW; Lee SH; Han JW; Koh KN; Im HJ; Kang HJ; Park KD
    J Neurooncol; 2013 Sep; 114(3):329-38. PubMed ID: 23824533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy.
    Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
    Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
    Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.
    de Rezende ACP; Weltman E; Chen MJ; Helito JK; de Carvalho ÍT; Sakuraba RK; Silva NS; Cappellano AM; Hamerschlak N
    PLoS One; 2019; 14(12):e0226350. PubMed ID: 31860688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.
    Lai IC; Wong TT; Shiau CY; Hu YW; Ho DM; Chang KP; Guo WY; Chang FC; Liang ML; Lee YY; Chen HH; Yen SH; Chen YW
    Childs Nerv Syst; 2015 May; 31(5):683-91. PubMed ID: 25749900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced-volume radiotherapy for patients with localized intracranial nongerminoma germ cell tumors.
    De B; Cahlon O; Dunkel IJ; De Braganca KC; Khakoo Y; Gilheeney SW; Souweidane MM; Wolden SL
    J Neurooncol; 2017 Sep; 134(2):349-356. PubMed ID: 28660318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.
    Balmaceda C; Heller G; Rosenblum M; Diez B; Villablanca JG; Kellie S; Maher P; Vlamis V; Walker RW; Leibel S; Finlay JL
    J Clin Oncol; 1996 Nov; 14(11):2908-15. PubMed ID: 8918487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy.
    Odagiri K; Omura M; Hata M; Aida N; Niwa T; Ogino I; Kigasawa H; Ito S; Adachi M; Inoue T
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):632-8. PubMed ID: 22420962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Local Radiation and Intensified Combined Intrathecal Methotrexate and High-dose Chemotherapy for Intracranial Germ Cell Tumors.
    Yamasaki K; Okada K; Soejima T; Kosaka Y; Nagashima T; Hara J
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e551-e557. PubMed ID: 32398600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neuropsychological outcome of pediatric non-midline central nervous system germinoma treated with chemotherapy and reduced dose/volume irradiation: The Children's Hospital Los Angeles experience.
    Yeo KK; Kayser K; Margol AS; Wong KK; Robison N; Finlay J; Dhall G
    Pediatr Blood Cancer; 2019 Dec; 66(12):e27983. PubMed ID: 31502379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
    Calaminus G; Andreussi L; Garré ML; Kortmann RD; Schober R; Göbel U
    Klin Padiatr; 1997; 209(4):222-7. PubMed ID: 9293454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.